Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 2
1977 3
1978 3
1979 1
1980 5
1981 4
1982 3
1983 4
1984 2
1985 2
1986 5
1987 3
1988 5
1989 3
1990 2
1991 4
1992 4
1993 3
1995 4
1996 4
1997 4
1998 3
1999 5
2000 4
2001 1
2002 2
2003 3
2004 4
2005 2
2006 2
2007 2
2008 2
2009 4
2010 6
2011 4
2012 4
2013 2
2014 3
2015 3
2016 1
2018 1
2019 1
2020 1
2021 2
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

123 results
Results by year
Filters applied: . Clear all
Page 1
Combination of a Sindbis-SARS-CoV-2 Spike Vaccine and αOX40 Antibody Elicits Protective Immunity Against SARS-CoV-2 Induced Disease and Potentiates Long-Term SARS-CoV-2-Specific Humoral and T-Cell Immunity.
Scaglione A, Opp S, Hurtado A, Lin Z, Pampeno C, Noval MG, Thannickal SA, Stapleford KA, Meruelo D. Scaglione A, et al. Among authors: meruelo d. Front Immunol. 2021 Jul 29;12:719077. doi: 10.3389/fimmu.2021.719077. eCollection 2021. Front Immunol. 2021. PMID: 34394127 Free PMC article.
Combination of a Sindbis-SARS-CoV-2 spike vaccine and αOX40 antibody elicits protective immunity against SARS-CoV-2 induced disease and potentiates long-term SARS-CoV-2-specific humoral and T-cell immunity.
Scaglione A, Opp S, Hurtado A, Lin Z, Pampeno C, Noval MG, Thannickal SA, Stapleford KA, Meruelo D. Scaglione A, et al. Among authors: meruelo d. bioRxiv. 2021 Jun 2:2021.05.28.446009. doi: 10.1101/2021.05.28.446009. Preprint. bioRxiv. 2021. PMID: 34075383 Free PMC article. Updated.
Sindbis viral vectors target hematopoietic malignant cells.
Suzme R, Tseng JC, Levin B, Ibrahim S, Meruelo D, Pellicer A. Suzme R, et al. Among authors: meruelo d. Cancer Gene Ther. 2012 Nov;19(11):757-66. doi: 10.1038/cgt.2012.56. Epub 2012 Sep 7. Cancer Gene Ther. 2012. PMID: 22956041
123 results